NTM Flashcards

1
Q

What is the most common presentation of Nontuberculosis Mycobacterial Disease?

A

Cervical lymphadenitis

Other presentations include skin and soft tissue infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In which setting does pulmonary NTM disease most often occur?

A

In the setting of preexisting lung disease

Most commonly associated with cystic fibrosis (CF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What may cause disseminated NTM disease?

A

Immune compromise

Often due to HIV/AIDS or a variety of rare conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which complex is the most commonly encountered NTM?

A

Mycobacterium avium complex (MAC)

Includes species like M. avium, M. intracellulare, and M. chimaera.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prevalence of Nontuberculosis Mycobacterial Disease in the general population?

A

27.9 cases per 100,000 population

Rarely a cause of death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What percentage of cystic fibrosis patients are affected by Nontuberculosis Mycobacterial Disease?

A

6%–13%

Patients infected with MABSC are often younger and may include children.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the predominant risk factor for Nontuberculosis Mycobacterial Disease?

A

Human Immunodeficiency Virus Infection/Acquired Immune Deficiency Syndrome

CD4 cell count < 50 cells/mm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nearly all acquisition of NTM by children occurs from _______.

A

Environmental sources

Includes soil, water, dust, and aerosols.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are common clinical manifestations of Nontuberculous Mycobacteria Pulmonary Disease?

A
  • Chronic cough
  • Sputum production
  • Radiographic signs (pulmonary nodules, tree-in-bud opacities)
  • Bronchiectasis
  • Cavitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the clinical criteria for diagnosing Nontuberculous Mycobacteria Pulmonary Disease?

A

Patient must meet both microbiologic and clinical criteria

Appropriate exclusion of other diagnoses is required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What microbiologic criteria must be met for diagnosing Nontuberculous Mycobacteria Pulmonary Disease?

A

2 or more positive sputum cultures for the same NTM species

A single positive culture from a bronchial wash or tissue biopsy is also acceptable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

True or False: Making the diagnosis of NTM pulmonary disease requires initiation of treatment.

A

False

Diagnosis does not necessarily require treatment initiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the most common form of extrapulmonary Nontuberculous Mycobacteria Disease?

A

Lymphadenitis (cervical LN)

Skin and soft-tissue infections are less common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the symptoms of disseminated MAC disease?

A
  • Fever
  • Night sweats
  • Abdominal pain
  • Diarrhea
  • Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For a diagnosis of disseminated NTM disease, how many cultures are sufficient?

A

A single culture from a wound or blood

Treatment should be initiated immediately.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How long should Nontuberculous Mycobacteria Pulmonary Disease be treated?

A

12 months beyond culture conversion

Culture conversion is defined as 3 consecutive negative cultures.

17
Q

What is the initial treatment regimen for noncavitary NTM lung disease due to MAC?

A
  • Azithromycin
  • Rifamycin
  • Ethambutol
18
Q

Why is azithromycin preferred for treating MAC disease?

A

Once daily dosing and reduced interactions with rifampin

Compared to clarithromycin.

19
Q

What is the treatment regimen for Mycobacterium kansasii pulmonary disease?

A
  • Isoniazid
  • Rifampin
  • Ethambutol

Treatment is daily for at least 12 months.

20
Q

What complications arise in the treatment of Mycobacterium abscessus species complex (MABSC)?

A

Significant levels of in vitro resistance and need for intravenous antibiotics

Common adverse reactions and poor treatment outcomes are also concerns.

21
Q

What types of surgical treatment options are available for NTM lung disease?

A
  • Pneumonectomy
  • Lobectomy
  • Segmentectomy

Sometimes performed to improve treatment outcomes.

22
Q

What are some alternative drugs for treating NTM?

A
  • Fluoroquinolones
  • Clofazimine
  • Inhaled amikacin
  • Linezolid
  • Bedaquiline
23
Q

What is noted about outcomes associated with NTM in children?

A

Outcomes are not well reported in the literature.